Pharma Services

Supporting Pharmaceutical and Biologic Innovation

The discovery, development, and commercialization of new pharmaceuticals and biologics relies on specialized service providers at every step. Both startup biotechs and large pharma companies outsource key processes — from lead identification to clinical trial management to regulatory submissions — to firms with deep subject matter expertise and industry relationships.

Mirus provides comprehensive coverage of the pharma services segment: preclinical and clinical CROs, clinical trial management, contract manufacturing, regulatory advisory, market access consultancies, packaging and distribution. Our team’s technical and industry expertise delivers a strong understanding of what drives value across the segment. From service differentiation and customer concentration to financial performance measures, we know what moves the needle on value and what diligence items can break deals.

What Clients Are Saying

“After 9 years building BPES’s position as a quality leader of custom process equipment to the biopharmaceutical industry, I wanted to transition the company to owners who see and can take advantage of the market opportunities arising from our participation in this fast-growing industry. The Mirus team successfully guided us through every aspect of the transaction, from identifying prospective buyers through closing. They conducted a thorough process and we are delighted by the outcome for BPES, its management team, and its shareholders.”

Joe Norton, Founder & ShareholderBioPharm Engineered Solutions

Meet Our Pharma Services Experts

Brendan Kiernan
Partner and Co-head of Business Services, Healthcare & Life Sciences
Brendan Kiernan Headshot | Mirus Capital Advisors
Patrick West
Partner & Co-head of Healthcare and Life Sciences
Patrick West Headshot | Mirus Capital Advisors
Thom Busby
Partner and Co-head of Healthcare & Life Sciences
Thom Busby Headshot | Mirus Capital Advisors
Nick Frame, PhD
Director
Nick Frame Headshot | Mirus Capital Advisors

Featured Report

Healthcare Sector | Mirus Pharma Services Report | Mirus Capital Advisors

Pharma Services: Q3 2025

An in-depth look at the Q3 2025 Pharma Services sector, where Mirus’ partners apply their expertise and experience to take a closer look at news, transactions, and state of the industry.

Download Report

News & Insights

December 8, 2025

Mirus Capital Advisors Recognized as “Investment Bank of the Year – Complex Transactions” at M&A Advisor Awards

Read More
September 16, 2025

Mirus Capital Advisors Expands Life Sciences & Healthcare Investment Banking Team with Strategic Additions of Thomas Busby and Nick Frame, PhD

Read More

Let’s Start a Conversation

Leverage our team’s expertise for your Pharma Services company.

Name(Required)